Carcinoembryonic antigen cell adhesion molecule 6 (CEACAM6) in Pancreatic Ductal Adenocarcinoma (PDA): An integrative analysis of a novel therapeutic target
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Carcinoembryonic antigen cell adhesion molecule 6 (CEACAM6) in Pancreatic Ductal Adenocarcinoma (PDA): An integrative analysis of a novel therapeutic target
Authors
Keywords
-
Journal
Scientific Reports
Volume 9, Issue 1, Pages -
Publisher
Springer Science and Business Media LLC
Online
2019-12-04
DOI
10.1038/s41598-019-54545-9
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Reshaping the Tumor Stroma for Treatment of Pancreatic Cancer
- (2018) Claire Vennin et al. GASTROENTEROLOGY
- High expression of TMEM40 is associated with the malignant behavior and tumorigenesis in bladder cancer
- (2018) Zhen-Fei Zhang et al. Journal of Translational Medicine
- Drug Repurposing Screening Identifies Tioconazole as an ATG4 Inhibitor that Suppresses Autophagy and Sensitizes Cancer Cells to Chemotherapy
- (2018) Pei-Feng Liu et al. Theranostics
- Therapeutic trends in pancreatic ductal adenocarcinoma (PDAC)
- (2018) Sreenivasa Chandana et al. EXPERT OPINION ON INVESTIGATIONAL DRUGS
- Characterization of the CLASP2 Protein Interaction Network Identifies SOGA1 as a Microtubule-Associated Protein
- (2017) Rikke Kruse et al. MOLECULAR & CELLULAR PROTEOMICS
- Survival of pancreatic cancer cells lacking KRAS function
- (2017) Mandar Deepak Muzumdar et al. Nature Communications
- IL2RG, identified as overexpressed by RNA-seq profiling of pancreatic intraepithelial neoplasia, mediates pancreatic cancer growth
- (2017) Michael Ayars et al. Oncotarget
- Co-targeting aurora kinase with PD-L1 and PI3K abrogates immune checkpoint mediated proliferation in peripheral T-cell lymphoma: a novel therapeutic strategy
- (2017) Shariful Islam et al. Oncotarget
- CEACAM1 as a Multi-Purpose Target for Cancer Immunotherapy
- (2017) Matthew Dankner et al. OncoImmunology
- Immune Cytolytic Activity Stratifies Molecular Subsets of Human Pancreatic Cancer
- (2016) David Balli et al. CLINICAL CANCER RESEARCH
- Genomic analyses identify molecular subtypes of pancreatic cancer
- (2016) Peter Bailey et al. NATURE
- Stromal Palladin Expression Is an Independent Prognostic Factor in Pancreatic Ductal Adenocarcinoma
- (2016) Daisuke Sato et al. PLoS One
- Immune checkpoint therapy for pancreatic cancer
- (2016) Henrik Johansson et al. WORLD JOURNAL OF GASTROENTEROLOGY
- Identification of key regulators of pancreatic cancer progression through multidimensional systems-level analysis
- (2016) Deepa Rajamani et al. Genome Medicine
- Insulitis and β-Cell Mass in the Natural History of Type 1 Diabetes
- (2015) Martha Campbell-Thompson et al. DIABETES
- Virtual microdissection identifies distinct tumor- and stroma-specific subtypes of pancreatic ductal adenocarcinoma
- (2015) Richard A Moffitt et al. NATURE GENETICS
- limma powers differential expression analyses for RNA-sequencing and microarray studies
- (2015) Matthew E. Ritchie et al. NUCLEIC ACIDS RESEARCH
- Diverse oligomeric states of CEACAM IgV domains
- (2015) Daniel A. Bonsor et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- A Meta Analysis of Pancreatic Microarray Datasets Yields New Targets as Cancer Genes and Biomarkers
- (2014) Nalin C. W. Goonesekere et al. PLoS One
- Complex role for the immune system in initiation and progression of pancreatic cancer
- (2014) Kristin S Inman WORLD JOURNAL OF GASTROENTEROLOGY
- voom: precision weights unlock linear model analysis tools for RNA-seq read counts
- (2014) Charity W Law et al. GENOME BIOLOGY
- Carcinoembryonic antigen-related cell adhesion molecules (CEACAMs) in cancer progression and metastasis
- (2013) Nicole Beauchemin et al. CANCER AND METASTASIS REVIEWS
- Glutaminase regulation in cancer cells: a druggable chain of events
- (2013) William P. Katt et al. DRUG DISCOVERY TODAY
- Small proline-rich repeat protein 3 enhances the sensitivity of esophageal cancer cells in response to DNA damage-induced apoptosis
- (2013) Aiping Luo et al. Molecular Oncology
- Subtypes of pancreatic ductal adenocarcinoma and their differing responses to therapy
- (2011) Eric A Collisson et al. NATURE MEDICINE
- Developmental factor IRF6 exhibits tumor suppressor activity in squamous cell carcinomas
- (2011) E. Botti et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Differential expression analysis for sequence count data
- (2010) Simon Anders et al. GENOME BIOLOGY
- A Gene Expression Signature Associated with “K-Ras Addiction” Reveals Regulators of EMT and Tumor Cell Survival
- (2009) Anurag Singh et al. CANCER CELL
- FKBP51 Affects Cancer Cell Response to Chemotherapy by Negatively Regulating Akt
- (2009) Huadong Pei et al. CANCER CELL
- Design and Activity of a Murine and Humanized Anti-CEACAM6 Single-Chain Variable Fragment in the Treatment of Pancreatic Cancer
- (2009) C. J. Riley et al. CANCER RESEARCH
- Translational advances and novel therapies for pancreatic ductal adenocarcinoma: hope or hype?
- (2009) Sreenivasa Chandana et al. EXPERT REVIEWS IN MOLECULAR MEDICINE
- The interaction of Thrombospondins with extracellular matrix proteins
- (2009) Kemin Tan et al. Journal of Cell Communication and Signaling
- Regulation of the Atheroma-Enriched Protein, SPRR3, in Vascular Smooth Muscle Cells through Cyclic Strain is Dependent on Integrin α1β1/Collagen Interaction
- (2008) Amy L. Pyle et al. AMERICAN JOURNAL OF PATHOLOGY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now